Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs
NCT02327832
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Liver Regeneration
Interventions
PROCEDURE:
Autologous BMSCs
DRUG:
bone marrow-derived mesenchymal stem cells
Sponsor
Yamaguchi University Hospital